Memorial Sloan Kettering Cancer Center’s VanEck Gold Miners ETF GDX Stock Holding History

Memorial Sloan Kettering Cancer Center’s Portfolio GDX Stock Details GDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$19.9M	Hold	738,500	–	–	80.92%	1
2023 Q2	$22.2M	Hold	738,500	–	–	70.19%	1
2023 Q1	$23.9M	Hold	738,500	–	–	73.26%	1
2022 Q4	$21.2M	Hold	738,500	–	–	69.82%	1
2022 Q3	$17.8M	Hold	738,500	–	–	60.55%	1
2022 Q2	$20.2M	Hold	738,500	–	–	66.82%	1
2022 Q1	$28.3M	Hold	738,500	–	–	32.79%	2
2021 Q4	$23.7M	Hold	738,500	–	–	14.86%	2
2021 Q3	$21.8M	Hold	738,500	–	–	13.56%	2
2021 Q2	$25.1M	Hold	738,500	–	–	16.41%	2
2021 Q1	$24M	Hold	738,500	–	–	14.79%	2
2020 Q4	$26.6M	Buy	+738,500	New	+$27.6M	11.26%	2

Other funds holding GDX

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return

Memorial Sloan Kettering Cancer Center's GDX Position: Q3 2023 in Review

Memorial Sloan Kettering Cancer Center held its VanEck Gold Miners ETF (GDX) position steady in Q3 2023 at 738,500 shares worth $19.9M. The position accounts for 80.92% of the portfolio, ranked #1.

Memorial Sloan Kettering Cancer Center first reported a position in GDX in Q4 2020 and has held it in 12 quarters since. The position peaked at $28.3M in Q1 2022. 708 funds tracked by Wall St. Rank hold GDX as of Q3 2023.

Memorial Sloan Kettering Cancer Center held 738,500 shares of VanEck Gold Miners ETF worth $19.9M as of Q3 2023.
Memorial Sloan Kettering Cancer Center left its VanEck Gold Miners ETF share count unchanged in Q3 2023.
VanEck Gold Miners ETF made up 80.92% of Memorial Sloan Kettering Cancer Center's portfolio in Q3 2023, its #1 holding.
Memorial Sloan Kettering Cancer Center first reported a position in VanEck Gold Miners ETF in Q4 2020 and has held it in 12 quarters since.
Memorial Sloan Kettering Cancer Center's VanEck Gold Miners ETF position peaked at $28.3M in Q1 2022.
708 funds tracked by Wall St. Rank held VanEck Gold Miners ETF as of Q3 2023.

Based on Memorial Sloan Kettering Cancer Center's 13F filing for Q3 2023, filed 14 Nov 2023.